433 related articles for article (PubMed ID: 29065127)
1. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
3. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
[TBL] [Abstract][Full Text] [Related]
4. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
[TBL] [Abstract][Full Text] [Related]
5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
6. Age Specific Cytological Abnormalities in Women Screened for Cervical Cancer in the Emirate of Abu Dhabi.
Al Zaabi M; Al Muqbali S; Al Sayadi T; Al Ameeri S; Coetsee K; Balayah Z; Ortashi O
Asian Pac J Cancer Prev; 2015; 16(15):6375-9. PubMed ID: 26434845
[TBL] [Abstract][Full Text] [Related]
7. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
Whop LJ; Baade P; Garvey G; Cunningham J; Brotherton JM; Lokuge K; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig DM; Moore SP; Condon JR
PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
9. Screening frequency and atypical cells and the prediction of cervical cancer risk.
Chen YY; You SL; Koong SL; Liu J; Chen CA; Chen CJ;
Obstet Gynecol; 2014 May; 123(5):1003-1011. PubMed ID: 24785853
[TBL] [Abstract][Full Text] [Related]
10. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
11. Association between concurrent genital bleeding and cervical cancer: a cross-sectional study.
Xavier-Júnior JC; Vale DB; Zeferino LC; Dufloth RM
Acta Obstet Gynecol Scand; 2015 Sep; 94(9):949-53. PubMed ID: 26033639
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
Dhanasekaran K; Verma C; Kumar V; Hariprasad R; Gupta R; Gupta S; Mehrotra R
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1265-1269. PubMed ID: 31030504
[TBL] [Abstract][Full Text] [Related]
13. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
Misra JS; Srivastava AN; Gupta HP
Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.
Donkoh ET; Agyemang-Yeboah F; Asmah RH; Wiredu EK
Medicine (Baltimore); 2019 Mar; 98(13):e14600. PubMed ID: 30921178
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
Wang J; Elfström KM; Andrae B; Nordqvist Kleppe S; Ploner A; Lei J; Dillner J; Sundström K; Sparén P
Int J Cancer; 2020 Mar; 146(5):1230-1240. PubMed ID: 31107987
[TBL] [Abstract][Full Text] [Related]
16. Risk for Cervical Intraepithelial Neoplasia Grade 3 or Higher in Follow-Up of Women With a Negative Cervical Biopsy.
Tverelv LR; Sørbye SW; Skjeldestad FE
J Low Genit Tract Dis; 2018 Jul; 22(3):201-206. PubMed ID: 29543686
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pre-malignant cervical lesions in females presenting with abnormal pelvic complaints.
Tahir QA; Bukhari MH
J Pak Med Assoc; 2020 Feb; 70(2):272-275. PubMed ID: 32063620
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
19. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
